Doxorubicin works primarily by intercalating into DNA, disrupting the replication process, and inhibiting the enzyme topoisomerase II. This action prevents the cancer cells from dividing and growing, ultimately leading to cell death. However, these mechanisms can also affect healthy cells, contributing to its toxic profile.
